pathogen
util
uniqu
rout
enter
cell
may
evad
intracellular
barrier
encount
typic
clathrinmedi
endocyt
pathway
retrograd
transport
caveolar
uptak
among
better
character
pathway
altern
clathrinmedi
endocytosi
known
facilit
entri
pathogen
potenti
deliveri
agent
recent
character
traffick
mechan
prion
protein
certain
bacteria
may
present
new
paradigm
strateg
improv
therapeut
spread
retent
therapi
review
provid
overview
endocyt
pathway
discuss
current
futur
possibl
use
rout
mean
improv
therapeut
deliveri
studi
gene
therapi
drug
target
brought
light
import
identifi
cellular
intracellular
barrier
effici
deliveri
accordingli
broad
audienc
made
awar
recent
year
characterist
typic
traffick
pathway
mani
target
therapeut
advanc
drug
deliveri
review
wwwelseviercomlocateaddr
pathway
character
receptor
bind
follow
cell
entri
via
receptormedi
endocytosi
clathrinco
pit
vesicl
deliveri
earli
endosom
passag
late
endosomeslysosom
cargo
degrad
otherwis
take
place
ligandreceptor
pair
virus
pathogen
well
nonvir
gene
deliveri
vector
known
enter
cell
rout
target
therapeut
gene
deliveri
vector
impart
therapeut
efficaci
howev
degrad
pathway
must
somehow
avoid
endocyt
pathway
classic
clathrinmedi
endocytosi
target
endosomallysosom
compart
better
character
recent
year
pathway
may
offer
altern
uptak
traffick
rout
gene
deliveri
vector
target
therapeut
may
avoid
barrier
pose
classic
rout
exampl
retrograd
transport
pathway
use
plant
bacteri
toxin
facilit
endocyt
traffick
cell
surfac
golgi
golgi
endoplasm
reticulum
er
revers
classic
secret
fig
toxin
make
use
cell
protein
audit
system
becom
transport
cytoplasm
toxic
activ
take
place
endocytosi
via
caveola
wellstudi
rout
similar
pathogen
util
caveolar
uptak
infect
character
recent
year
pathway
caveolar
vesicl
fuse
caveosom
facilit
prolong
surviv
pathogen
cell
transit
er
nuclear
entri
take
place
viral
replic
fig
format
replicationcompet
vacuol
insid
cell
strategi
use
brucella
similar
pathogen
gain
longterm
surviv
insid
host
cell
pathway
typifi
endocytosi
pathogencontain
vacuol
deliveri
interact
er
follow
format
erderiv
replic
organel
fig
endocyt
pathway
may
also
lead
effect
deliveri
spread
neighbor
cell
secret
exosom
like
enabl
prion
protein
transmit
cell
cell
fig
studi
pathway
import
therapeut
deliveri
deliveri
lysosom
compart
pose
one
major
barrier
gene
drug
deliveri
appeal
use
virus
viral
compon
target
therapeut
partli
due
capac
endosom
escap
thu
avoid
lysosom
degrad
penetr
membran
matur
vesicl
cargo
deliveri
lysosom
peptid
deriv
sever
type
pathogen
use
accomplish
peptid
thought
chang
conform
respons
acidifi
environ
endosom
lumen
result
interact
endosom
membran
form
pore
destabil
lipid
bilay
thu
afford
vesicl
escap
event
gene
deliveri
vector
escap
endocyt
vesicl
cytosol
factor
still
pose
addit
barrier
crowd
cytosol
milieu
prevent
rapid
vector
motil
nucleu
cytosol
nucleas
degrad
dna
cargo
altern
endocyt
pathway
describ
may
contribut
toward
improv
therapeut
deliveri
facilit
avoid
lysosom
deliveri
degrad
enhanc
deliveri
target
organel
golgi
er
nucleu
compart
cytoplasm
enhanc
longterm
therapi
format
extranuclear
replic
organel
clear
one
rout
enter
cell
studi
varieti
pathogen
show
altern
endocyt
pathway
cleverli
hijack
avoid
degrad
fate
evad
cell
defens
examin
pathway
may
serv
possibl
rout
improv
therapeut
deliveri
plant
toxin
ricin
abrin
bacteri
toxin
shiga
toxin
stx
cholera
toxin
ctx
pseudomona
exotoxin
pex
enter
cell
follow
rout
revers
classic
secretori
pathway
classic
secret
character
transport
newli
synthes
protein
er
golgi
follow
bud
vesicul
cargo
transgolgi
network
vesicl
sort
cytoplasm
fusion
plasma
membran
mani
type
virus
similar
pathogen
directli
access
cytoplasm
fig
retrograd
transport
plant
bacteri
toxin
initi
bind
cellsurfac
molecul
trigger
receptormedi
endocytosi
deliveri
earli
sort
endosom
toxin
may
undergo
deliveri
tgn
either
earli
late
endosom
tgn
toxin
may
transit
golgi
cisterna
becom
transport
er
either
kdel
receptordepend
independ
pathway
altern
transport
may
take
place
directli
tgn
er
toxin
displac
er
pore
cytoplasm
translat
machineri
access
endocyt
vesicl
endocytosi
toxin
follow
retrograd
rout
classic
secret
accomplish
certain
plant
bacteri
toxin
share
common
structur
compris
two
major
domain
chain
term
b
chain
form
catalyt
toxic
domain
wherea
b
chain
respons
cell
bind
proform
protein
nontox
wherea
proteolyt
cleavag
insid
cell
activ
toxin
cell
entri
pex
ricin
cleavag
releas
subunit
wherea
ctx
stx
subunit
separ
chain
target
toxic
activ
specif
compon
protein
synthesi
machineri
chain
stx
ricin
rna
nglycosidas
remov
conserv
adenin
residu
rrna
site
interact
elong
factor
ef
ternari
complex
effect
inhibit
protein
synthesi
lead
cell
death
ctx
chain
adpribosyltransferas
modifi
heterotrimer
g
protein
activ
adenylyl
cyclas
induc
intestin
chlorid
secret
pseudomona
exotoxin
chain
adpribosyl
prevent
protein
synthesi
lead
cell
death
toxic
activ
requir
interact
protein
synthesi
molecul
toxin
depend
deliveri
cytoplasm
access
machineri
consist
pathogen
infect
mechan
toxin
cell
entri
enabl
bind
cellsurfac
molecul
thu
trigger
endocyt
uptak
infect
stx
ctx
initi
b
chain
bind
host
cell
membran
glycolipid
stx
bind
trisaccharid
domain
globotriaosylceramid
gb
wherea
ctx
bind
gangliosid
pex
b
chain
bind
macroglobulin
receptorlowdens
lipoprotein
receptorrel
protein
ricin
b
chain
lectin
bind
link
galactosid
display
wide
rang
cellsurfac
glycoprotein
glycolipid
thu
owe
promiscu
ricin
cellsurfac
bind
trigger
intern
toxin
endocyt
vesicl
undergo
lumen
acidif
vesicl
matur
late
endosom
fig
typic
cargo
late
endosom
would
becom
degrad
due
vesicl
fusion
lysosom
contain
proteolyt
enzym
vesicul
toxin
evad
fate
transit
tgn
either
earli
late
endosom
fig
pathway
depend
least
part
lipid
associ
certain
rab
specif
vesicl
tgn
receptor
known
snare
solubl
nethylmaleimidesensit
fusion
attach
protein
receptor
associ
lipid
rich
membran
domain
common
mode
cell
uptak
accordingli
stx
ctx
associ
deterg
resist
membran
microdomain
drm
undergo
transport
earli
endosom
pex
hand
undergo
lipidindepend
transport
late
endosom
tgn
late
endosom
pathway
use
pex
depend
upon
small
gtpase
transport
earli
endosom
tgn
rout
use
ctx
stx
ricin
transport
cargo
endocyt
vesicl
target
organel
entail
fusion
vesicl
target
membran
requir
interact
specif
vesicl
target
membran
snare
vsnare
tsnare
respect
correspondingli
earli
endosom
tgn
late
endosom
tgn
pathway
depend
contribut
snare
rout
character
separ
vsnare
tsnare
vesicul
toxin
reach
tgn
cargo
transport
endoplasm
reticulum
er
via
sever
rout
fig
one
golgi
cisterna
interact
kdel
receptor
cycl
tgn
er
coatam
protein
complex
depend
manner
protein
complex
coat
vesicl
bud
golgi
apparatu
sort
vesicul
cargo
base
interact
cytoplasm
domain
membran
protein
kdel
receptor
recogn
bind
kdel
motif
cargo
protein
respons
retriev
escap
er
protein
golgi
pex
contain
kdellik
sequenc
expos
chain
releas
furin
cleavag
earlyrecycl
endosom
lipidsort
pathway
use
stx
kdel
receptor
control
pex
may
also
use
pathway
third
poorli
character
pathway
bypass
golgi
cisterna
instead
transport
cargo
directli
tgn
er
kdel
receptor
manner
ctx
use
pathway
despit
exist
kdel
motif
peptid
sequenc
possibl
motif
function
retain
ctx
er
deliveri
prevent
possibl
anterograd
transport
golgi
ricin
may
util
pathway
ricin
lack
kdel
sequenc
evid
show
bind
chaperon
calreticulin
kdel
motif
undergo
traffick
er
ricin
elicit
cell
death
classic
pathway
inhibit
suggest
ricin
bypass
golgi
stack
along
similar
pathway
ctx
ricin
bind
glycolipid
contain
termin
galactos
may
also
follow
lipidsort
pathway
toxin
reach
er
thought
cytoplasm
access
take
advantag
protein
audit
system
er
known
erad
erassoci
protein
degrad
mechan
elimin
misfold
protein
er
discard
cytoplasm
pore
known
translocon
term
dislocon
fig
typic
protein
ubiquitin
target
proteasom
degrad
howev
toxin
contain
abnorm
low
lysin
content
thu
poor
substrat
ubiquitin
henc
spare
degrad
surviv
cytoplasm
access
protein
synthesi
machineri
similar
type
bacteri
toxin
diphtheria
toxin
directli
penetr
endosom
membran
cytosol
thu
avoid
retrograd
rout
altogeth
featur
util
deliveri
exogen
gene
peptid
cytoplasm
gene
deliveri
conjug
also
produc
test
make
use
compon
toxin
like
pex
undergo
retrograd
traffick
exampl
multidomain
fusion
protein
contain
transloc
domain
pex
use
deliv
gene
cytosol
whether
conjug
actual
traffick
similar
fashion
wildtyp
pex
unknown
though
appear
intent
molecular
design
breach
endosom
membran
shiga
toxin
cholera
toxin
also
enter
cytoplasm
er
test
gene
transfer
agent
though
like
pex
deriv
vector
clear
whether
agent
traffic
wildtyp
toxin
use
gene
deliveri
protein
toxin
also
use
gener
specif
cytotox
lymphocyt
ctl
activ
certain
epitop
deliveri
antigen
peptid
fusion
modifi
toxin
facilit
cytosol
entri
antigen
degrad
proteasom
display
mhc
class
molecul
prime
ctl
respons
approach
gener
new
type
vaccin
use
deliv
epitop
via
pex
stx
type
toxin
molecular
player
toxinretrograd
traffick
pathway
better
character
may
possibl
util
rout
mean
target
compound
specif
organel
contribut
pathway
one
could
envisag
design
new
molecul
interact
target
cell
similarli
toxin
discuss
mimic
toxin
traffick
pathway
deliv
peptid
specif
golgi
er
perhap
correct
defect
elicit
toxic
treatment
cancer
moreov
given
avoid
lysosom
perhap
rout
could
better
use
gene
deliveri
enabl
greater
surviv
gene
therapi
vector
target
cell
entri
cellular
prion
protein
prp
c
glycosylphosphatidylinositol
gpi
anchor
protein
ubiquit
express
though
found
higher
level
neuron
nonneuron
tissu
immun
cell
function
prp
c
remain
unclear
thought
contribut
copper
andor
zinc
ion
transport
metabol
protect
oxid
stress
cellular
signal
membran
excit
synapt
transmiss
apoptosi
neurit
outgrowth
diseas
associ
prion
occur
prp
c
undergo
convers
scrapi
form
prp
sc
result
transconform
structur
prp
sc
seed
convers
reaction
thu
greatli
increas
rate
transconform
result
molecul
oligomer
amyloid
fibril
acquir
tendenc
form
amyloid
deposit
brain
tissu
human
prion
diseas
inherit
due
mutat
prion
protein
gene
infecti
form
caus
kuru
creutzfeltjakob
diseas
human
scrapi
sheep
bovin
spongiform
encephalopathi
cattl
thought
enter
host
gastrointestin
tract
becom
acquir
peripher
nerv
lymphoid
tissu
replic
take
place
invas
central
nervou
system
like
due
transfer
via
phagocyt
mononuclear
cell
transfer
infecti
agent
cell
cell
hypothes
occur
via
exosom
vesicl
secret
cell
surfac
synthesi
prp
c
secret
cell
surfac
gpi
anchor
insert
plasma
membran
lipid
raft
domain
within
lipid
bilay
exhibit
order
assembl
specif
lipid
usual
glycosphingolipid
cholesterol
compar
surround
plasma
membran
prp
c
constitut
endocytos
via
either
clathrinco
vesicl
caveola
fig
like
depend
cell
type
lipid
microenviron
intern
prp
c
traffic
late
endosomeslysosom
steadi
state
fraction
local
multivesicular
bodi
mvb
neuron
brain
nonneuron
cell
mvb
form
pinch
cytosolfil
intralumin
vesicl
ilv
endosom
lumen
fig
sort
cargo
ilv
involv
least
protein
tightli
regul
process
among
cellular
factor
contribut
process
endosom
sort
complex
requir
transport
escrt
machineri
cytosol
protein
select
sort
cargo
ilv
process
ubiquitin
cargo
protein
recogn
hr
complex
protein
recruit
escrti
complex
also
recogn
ubiquitin
cargo
recruit
escrtiii
via
escrtii
alix
togeth
sequest
cargo
protein
inwardbud
ilv
mvb
either
fuse
lysosom
plasma
membran
plasma
membran
fusion
enabl
releas
ilv
known
exosom
extracellularli
fig
exosom
may
serv
mode
intercellular
commun
mean
discard
protein
may
exploit
pathogen
diseas
transmiss
prp
sc
prp
c
detect
cell
cultur
supernat
associ
secret
exosom
exosom
elicit
convers
endogen
prp
c
prp
sc
incub
host
cell
caus
acut
typic
neuropatholog
inocul
mice
find
suggest
exosom
may
facilit
transfer
infecti
prion
agent
releas
exosom
may
transport
associ
cargo
remot
well
neighbor
cell
like
explain
prion
may
deliv
site
distant
site
introduct
transfer
protein
recipi
cell
thought
take
place
interact
exosom
recipi
cell
membran
two
possibl
type
mechan
fig
one
mechan
direct
fusion
exosom
plasma
membran
thu
transfer
content
exosom
membran
plasma
membran
suggest
observ
recipi
cell
receiv
incom
prp
sc
recipi
raft
domain
exchang
membran
compon
take
place
exosom
recipi
cell
like
mechan
howev
exosom
undergo
endocyt
uptak
recipi
cell
backfus
limit
membran
endocyt
vesicl
thu
transfer
exosom
membran
content
exosom
deliveri
transconform
activ
support
mechan
convers
process
thought
occur
low
ph
gene
therapi
treatment
solid
tumor
reli
effici
deliveri
mani
cell
possibl
obtain
potent
level
gene
express
potenti
tumor
ablat
howev
deliveri
gene
cell
tumor
may
improb
task
express
gene
product
somehow
spread
therapeut
effect
neighbor
cell
feasibl
approach
thu
use
herp
simplex
viru
thymidin
kinas
hsvtk
gene
therapeut
transgen
sustain
great
appeal
gene
therapi
due
bystand
effect
caus
toxic
enzym
product
effect
describ
abil
hsvtk
enzym
product
triphosphoryl
ganciclovir
spread
neighbor
cell
via
gap
junction
within
solid
tumor
wherea
substrat
effect
cell
recent
attempt
made
enhanc
effect
produc
tk
recombin
fusion
protein
abil
becom
secret
express
cell
taken
neighbor
cell
mechan
remain
unclear
capac
secret
exosom
produc
cell
taken
neighbor
well
remot
cell
target
could
potent
mean
deliv
effici
level
therapeut
cell
target
one
could
envisag
abil
modifi
exosom
membran
bound
target
ligand
perhap
limit
spread
therapeut
surround
tumor
tissu
time
target
remot
metastat
tumor
modifi
exosom
contain
therapeut
protein
compound
could
effici
deliv
therapi
recipi
cell
fusion
exosom
membran
recipi
cell
membran
thu
releas
product
directli
target
cell
character
pathogen
cellular
factor
contribut
process
would
determin
whether
approach
therapeut
dissemin
could
feasibl
option
futur
caveola
flaskshap
invagin
plasma
membran
character
coat
compris
mostli
palmityl
cholesterolbind
protein
caveola
regul
sever
differ
signal
cascad
thu
caveolin
defect
contribut
broad
rang
diseas
includ
cancer
cardiovascular
diseas
diabet
atherosclerosi
pulmonari
fibrosi
muscular
dystrophi
certain
mammalian
virus
polyomavirus
influenza
virus
coronavirus
echoviru
use
caveolaemedi
transport
cell
surfac
enter
cell
traffick
simian
viru
nonenvelop
dna
viru
papovaviru
famili
extens
studi
follow
pathway
caveolaemedi
transport
facilit
nuclear
deliveri
viru
avoid
endosomallysosom
degrad
rout
bind
two
receptor
one
gangliosid
locat
lipid
raft
major
histocompat
mhc
class
viru
bind
induc
receptor
cluster
sequestr
lipid
raft
associ
receptorviru
complex
caveola
fig
bind
also
induc
cascad
signal
event
includ
tyrosin
kinas
phosphoryl
protein
kinas
c
activ
contribut
caveolar
format
endocytosi
one
downstream
effect
signal
actin
depolymer
facilit
caveolar
intern
recruit
pinch
caveolar
neck
releas
caveolar
vesicl
term
cavicl
mhc
class
molecul
endocytos
viru
releas
cell
surfac
caveolar
vesicl
requir
intact
microtubul
traffic
within
cell
suggest
dynein
motor
may
contribut
motil
vesicl
may
fuse
endosom
clathrinmedi
pathway
caveosom
ph
neutral
compart
rich
cholesterol
glycosphingolipid
fig
noninfect
cell
compart
like
serv
intermedi
depot
transport
sphingolipid
gpilink
protein
plasma
membran
golgi
apparatu
deliveri
caveosom
retain
compart
sever
hour
contrast
find
uninfect
cell
show
caveosom
may
mediat
receptor
turnov
suggest
deliveri
function
caveosom
depend
protein
cargo
caveosom
sort
carrier
traffic
along
microtubul
er
fig
copi
copiico
carrier
vesicl
may
contribut
process
thought
somehow
penetr
cytosol
deliveri
er
nuclear
entri
gain
via
nuclear
pore
complex
fig
altern
rapid
endocyt
pathway
may
directli
intern
via
lipid
raft
manner
vesicul
organel
pathway
identifi
could
infect
knockout
mous
cell
molecular
mechan
contribut
caveolarmedi
traffick
remain
fulli
character
even
role
caveolin
unclear
express
cell
lack
caveola
suffici
gener
caveolar
format
wherea
overexpress
inhibit
propos
stabil
caveolar
invagin
wherea
intermedi
rapidli
bud
cell
membran
endocytos
may
partli
explain
find
use
green
fluoresc
protein
gfp
tag
show
larg
pool
immobil
caveolin
exist
cultur
cell
report
addit
traffick
pathway
suggest
caveola
mediat
slow
endocytosi
requir
sequestr
cargo
cell
surfac
intern
contrast
rapid
endotheli
transcytosi
mediat
caveola
vivo
observ
use
specif
target
nanoparticl
studi
demonstr
vivo
circul
particl
target
caveola
rapidli
cross
endothelium
underli
basement
membran
accumul
interstiti
space
lung
tissu
within
minut
contrast
find
latter
former
studi
may
depend
whether
studi
perform
vivo
cultur
cell
well
type
probe
use
traffick
studi
nonvir
gene
deliveri
vector
shown
vector
may
enter
cell
use
multipl
cell
entri
rout
rout
may
support
deliveri
degrad
pathway
caveolar
rout
use
may
spare
cargo
degrad
enabl
prolong
resid
cell
period
time
rout
er
given
cellular
protein
transform
growth
factor
receptor
elicit
receptor
signal
intern
via
clathrinco
pit
wherea
caveosom
uptak
promot
receptor
turnov
appear
use
caveosom
mean
evad
degrad
would
depend
modul
vesicl
cargo
regard
studi
character
molecular
interact
pathogen
like
host
cell
enabl
pathogen
surviv
caveosom
would
use
shown
particl
resembl
nonvir
gene
deliveri
vector
util
either
clathrin
caveolarmedi
uptak
cell
depend
particl
size
vector
protein
may
enter
cell
via
differ
rout
rout
appear
support
gene
transfer
other
accumul
studi
vector
traffick
show
howev
fig
traffick
via
caveola
caveosom
bound
cell
surfac
distribut
caveola
pinch
form
vesicl
releas
cell
surfac
transport
caveosom
altern
may
directli
intern
via
lipid
raft
fuse
caveosom
transport
facilit
deliveri
caveosom
er
possibl
exit
cytosol
enter
nucleu
via
nuclear
pore
one
rout
consist
support
gene
transfer
exampl
recent
studi
shown
certain
polyplex
enter
cultur
cell
clathrin
caveolarmedi
pathway
yet
latter
pathway
preferenti
led
gene
express
wherea
inhibit
former
pathway
effect
revers
observ
histidinyl
polyplex
wherebi
clathrinmedi
endocytosi
appear
preferenti
support
gene
express
even
though
vector
enter
cell
clathrin
nonclathrinmedi
pathway
recent
studi
show
caveola
mediat
rapid
transcytosi
target
particl
across
endothelium
thu
enabl
access
deep
tissu
cell
vivo
demonstr
possibl
overcom
endotheli
barrier
target
tissu
circul
suggest
tumor
vasculatur
leaki
thu
facilit
accumul
therapeut
solid
tumor
normal
tissu
contain
differ
type
endothelium
may
easili
access
thu
target
endotheli
cellsurfac
protein
transport
molecul
across
vessel
wall
would
import
strategi
drug
gene
deliveri
pathogen
acquir
prolong
surviv
host
cell
form
vacuol
pathogen
resid
evad
host
defens
among
bacteri
pathogen
share
similar
vacuol
traffick
mechan
shigella
listeria
mycobacterium
salmonella
legionella
francisella
brucella
traffick
brucella
among
extens
studi
character
endocytosi
special
vacuol
interact
er
form
replic
organel
bacterium
establish
longterm
surviv
brucella
replic
insid
infect
host
cell
macrophag
caus
brucellosi
affect
broad
rang
mammal
includ
livestock
human
human
brucellosi
chronic
debilit
diseas
longterm
surviv
brucella
host
cell
contribut
diseas
chronic
chlamydia
also
form
pathogencontain
vacuol
cell
entri
c
pneunomia
cpn
associ
respiratori
tract
infect
includ
pneumonia
asthma
bronchiti
sinus
sarcoidosi
brucella
infect
initi
bind
bacteri
surfaceexpos
cellular
prion
protein
prp
c
prp
c
may
typic
undergo
clathrinmedi
endocytosi
brucella
somehow
abl
modul
endocyt
uptak
avoid
target
lysosom
degrad
pathway
instead
thought
uptak
occur
via
lipid
raft
endocytosi
lipid
raft
disrupt
affect
cell
entri
shortterm
surviv
replic
brucella
sui
brucella
abortu
endocyt
uptak
result
format
brucellacontain
vacuol
bcv
fig
interact
earli
endosom
avoid
fusion
late
endosomeslysosom
observ
absenc
gtpase
late
endosom
marker
vacuol
bcv
acquir
argu
compart
addit
late
endosomeslysosom
harbor
marker
bcv
vacuol
matur
undergo
acidif
come
close
contact
er
fig
bcv
interact
er
form
erderiv
replic
organel
establish
longterm
surviv
fig
epitheli
cell
replic
organel
erderiv
wherea
phagocyt
cell
bcv
dock
er
acquir
erspecif
marker
via
limit
fusion
event
fig
vacuol
replic
organel
format
membranebound
brucella
intern
brucellacontain
vacuol
bcv
either
fuse
earlysort
endosom
undergo
matur
entail
transit
er
interact
er
result
acquisit
er
marker
vacuol
undergo
matur
replic
organel
stage
organel
becom
permiss
bacteri
replic
requir
addit
membran
output
replic
like
provid
fusion
interact
er
membran
studi
l
pneumophila
show
biogenesi
erderiv
organel
requir
intercept
copi
vesicular
traffick
er
true
brucella
howev
block
traffick
effect
bcv
matur
replic
molecular
mechan
entri
surviv
still
unclear
though
virb
protein
receiv
much
attent
screen
brucella
surviv
mutant
gener
transposon
insert
identifi
virb
operon
encod
type
ivrel
secret
system
typic
secretesexport
nucleoprotein
complex
protein
contrast
wildtyp
brucella
virb
mutant
undergo
lipid
raftindepend
endocytosi
remain
immatur
vacuol
dock
er
sustain
fusion
er
ultim
target
degrad
pathway
thu
fail
reach
replic
nich
relev
virb
endocyt
entri
unclear
minor
ingest
wildtyp
bacteria
surviv
host
cell
suggest
major
intern
bacteria
escap
degrad
pathway
furthermor
studi
b
sui
show
virb
express
take
place
cell
entri
virb
like
involv
late
event
correspond
er
fusion
possibl
virb
mediat
transport
bacteri
effector
molecul
host
cell
may
modul
bcv
matur
gene
therapi
may
administ
temporari
shortterm
treatment
diseas
cancer
longterm
perman
solut
replac
correct
defect
gene
longterm
approach
typic
entail
use
viral
vector
capac
integr
gene
interest
host
genom
pose
seriou
concern
includ
possibl
gene
insert
activ
oncogen
effect
altern
dna
vector
contain
element
extrachromosom
retent
host
cell
may
support
longterm
though
perman
solut
transgen
deliveri
vein
perhap
extranuclear
organel
type
vacuol
provid
pathogen
like
brucella
may
enabl
longterm
resid
retent
gene
therapi
vector
drug
target
cell
bacteriallik
vector
consid
cancer
therapi
gene
therapi
mechan
format
pathogencontain
vacuol
replic
organel
need
character
studi
far
appear
suggest
intracellular
bodi
occur
result
interact
pathogen
gene
product
host
cell
factor
studi
identifi
player
interact
associ
function
may
direct
futur
effort
design
molecul
mimic
dynam
induc
format
similar
intracellular
organel
one
could
envisag
organel
use
longterm
intracellular
retent
therapeut
compound
gene
whose
releas
time
could
benefit
comparison
larg
potenti
toxic
bolu
dose
therapeut
may
requir
numer
repeat
dose
effect
develop
drug
gene
deliveri
direct
entri
traffick
therapeut
specif
intracellular
pathway
worthwhil
consider
typic
clathrinmedi
endocyt
pathway
use
mani
gene
therapi
vector
target
therapeut
introduc
common
cellular
barrier
altern
pathway
discuss
may
provid
mean
evad
barrier
moreov
pathway
may
facilit
deliveri
specif
organel
cellular
compart
futur
studi
molecular
mechan
mediat
pathogen
traffick
pathway
may
enabl
design
new
vector
deliveri
agent
improv
abil
direct
therapi
desir
intracellular
target
